The Biomedical Advanced Research and Development Authority (BARDA) helped bring Moderna’s mRNA vaccine through clinical trials to market. BARDA’s Division of Research, Innovation, and Ventures (DRIVe) is its in-house biotech venture capital firm, charged with identifying and incubating technologies for U.S. biodefense and preparedness.
Today's interviewee is Dr. Sandeep Patel, the Director of DRIVe from March 2020 to March 2024. Patel helped architect the program’s VC-inspired model and led the organization through its COVID response.
We covered:
(00:00) Introduction
(00:20) How cost-effective is BARDA?
(09:38) Venture-capitalism in government
(26:14) Hiring talent
(34:35) Question grab-bag
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit
www.statecraft.pub
